Nexium Capsules Helicobacter Pylori Specific Clinical Experience Investigation
The purpose of this study is to confirm the safety profile / factors which impact safety and efficacy in patients given triple therapy for Helicobacter pylori eradication with Nexium + amoxicillin (AMPC) + clarithromycin (CAM), or Nexium + AMPC + metronidazole (MNZ) in usual post-marketing use.
Gastric Ulcer|Duodenal Ulcer|Gastric Mucosa-associated Lymphoid Tissue (MALT)|Lymphoma Idiopathic Thrombocytopenic Purpura|Early Gastric Cancer
Number of Adverse Drug Reactions, Period from the start of triple therapy to assessment of eradication, an expected average of 3 months
Rate of H.Pylori eradication, Period from the start of triple therapy to assessment of eradication, an expected average of 3 months
Nexium capsules Specific Clinical Experience Investigation concerning Helicobacter pylori eradication